Novel Anti-respiratory Syncytial(RS) Viral Compounds: Benzodithiin Derivatives

Author： Watanabe W.   Sudo K.   Sato R.   Kajiyashiki T.   Konno K.   Shigeta S.   Yokota T.  

Publisher： Elsevier

ISSN： 0006-291X

Source： Biochemical and Biophysical Research Communications, Vol.249, Iss.3, 1998-08, pp. : 922-926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

XBP-1, a Cellular Target for the Development of Novel Anti-viral Strategies

By  

Current Protein and Peptide Science, Vol. 19, Iss. 2, 2017-12 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of Respiratory Syncytial Virus by 2_5A Antisense

By Cramer Hagen   Okicki James   Kuang Mei   Xu Zan  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 24, Iss. 5-7, 2005-04 ,pp. : 497-501

Taylor & Francis Ltd

Access to resources Recommend Favorite

Carriers for the delivery of a vaccine against respiratory syncytial virus

By Cranage Martin   Taylor Geraldine  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 939-952

Informa Healthcare

Access to resources Recommend Favorite

Motavizumab for the prevention of respiratory syncytial virus infection in infants

By Gill Michelle A   Welliver Robert C  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 10, 2009-10 ,pp. : 1335-1345

Informa Healthcare

Access to resources Recommend Favorite

Palivizumab in the prevention of respiratory syncytial virus disease

By Krilov Leonard R  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 763-769

Informa Healthcare

Access to resources Recommend Favorite